Arrowhead Pharmaceuticals Inc (ARWR) — Cash Flow Reinvestment Rate
Arrowhead Pharmaceuticals Inc (ARWR) has a Cash Flow Reinvestment Rate of 4.27x as of September 2025, reinvesting $87.60 Million (capex $7.49 Million plus investments $80.11 Million) from operating cash flow of $20.49 Million. Check Arrowhead Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arrowhead Pharmaceuticals Inc Cash Flow Reinvestment Rate (1997–2025)
Historical reinvestment intensity for Arrowhead Pharmaceuticals Inc across 4 annual periods. Explore Arrowhead Pharmaceuticals Inc (ARWR) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Arrowhead Pharmaceuticals Inc (1997–2025)
Year-by-year capital reinvestment analysis for Arrowhead Pharmaceuticals Inc. For live market cap and broader valuation context, see ARWR company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.85x | $151.96 Million | $179.55 Million | $22.67 Million | ▲ +2.3% |
| 2021 | 0.83x | $141.68 Million | $171.22 Million | $23.57 Million | ▲ +139.6% |
| 2019 | 0.35x | $59.75 Million | $173.03 Million | $12.00 Million | — |
| 1997 | 0.00x | $0.00 | $4.56K | $0.00 | — |